2010至2024年国家自然科学基金急诊与重症医学领域申请与资助情况分析
该研究基于国家自然科学基金资助系统,系统分析了2010至2024年急诊与重症医学领域(申请代码H16)所有项目申请与资助数据,包括申请数、资助数及金额、项目类别、地区与依托单位分布,并用VOSviewer进行关键词共现分析以识别研究热点。15年间共接收申请13747项,资助1781项,累计资助金额80.6499亿元;申请数从2010年的296项增至2024年的1971项,年均增长率40.42%,资助数从45项增至175项,年均增长率20.63%,年度资助金额从2010年的2001万元增至2024年的7420万元,年均增长率19.34%。资助项目以面上项目(774项)、青年科学基金(754项)和地区科学基金(163项)为主,合计占94.95%(1691/1781);资助集中在器官功能障碍与支持(H1602,751项)和脓毒症(H1601,612项)两个方向,合计占76.53%(1363/1781)。关键词共现分析显示脓毒症、器官损伤、肺损伤与中毒、心肺复苏为主要研究热点。
要点
- 2010至2024年急诊与重症医学领域共资助1781项,累计金额80.6499亿元,年度资助金额从2001万元增至7420万元。
- 面上项目(774项)、青年科学基金(754项)、地区科学基金(163项)合计占资助项目94.95%(1691/1781)。
- 器官功能障碍与支持(H1602,751项)和脓毒症(H1601,612项)合计占资助项目76.53%(1363/1781)。
- 急诊与重症医学领域资助项目总数(1781项)少于医学科学部各子领域平均资助数(4181项)。
- 关键词共现分析提示脓毒症、器官损伤、肺损伤与中毒、心肺复苏为主要研究热点。
研究设计与关键结果
- 研究类型为对国家自然科学基金资助系统2010至2024年急诊与重症医学领域(申请代码H16)项目申请与资助数据的系统分析,使用VOSviewer软件进行关键词共现分析。
- 15年间共接收项目申请13747项,资助1781项,累计资助金额80.6499亿元。
- 年度申请数从2010年的296项增至2024年的1971项,年均增长率40.42%;年度资助数从45项增至175项,年均增长率20.63%;年度资助金额从2001万元增至7420万元,年均增长率19.34%。
- 资助项目以面上项目(774项)、青年科学基金(754项)和地区科学基金(163项)为主,合计占94.95%(1691/1781)。
- 资助集中在器官功能障碍与支持(H1602,751项)和脓毒症(H1601,612项),合计占76.53%(1363/1781)。
- 急诊与重症医学领域资助项目总数(1781项)少于医学科学部各子领域平均资助数(4181项)。
- 资助项目数排名前五的地区为上海(305项,17.1%)、广东(222项,12.5%)、江苏(154项,8.6%)、浙江(149项,8.4%)、北京(134项,7.5%)。
- 关键词共现分析显示脓毒症、器官损伤、肺损伤与中毒、心肺复苏为过去15年主要研究热点。
证据类型、等级与局限
- 证据类型:基于国家自然科学基金资助系统数据的文献计量学分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically summarize and analyze the project applications and funding in the field of Emergency and Critical Care Medicine by the Medical Science Department of the National Natural Science Foundation of China (NSFC) from 2010 to 2024, and to identify research hotspots and developmental trends, providing scientific references for the high-quality development of the Emergency and Critical Care Medicine in China.
METHODS: Data on all project applications and funding in the field of Emergency and Critical Care Medicine (application code H16) from 2010 to 2024 were collected from the NSFC Grants System, including project application numbers, funding numbers and amounts, project categories, regional and affiliated institutions distributions. Keyword co-occurrence analysis was conducted using VOSviewer software to identify research hotspots, and results were presented using bar charts, pie charts, and Sankey diagrams.
RESULTS: Over the past 15 years, the Emergency and Critical Care Medicine field of NSFC received 13 747 project applications and funded 1 781 projects, with a cumulative funding amount of 8.064 99 billion RMB. The annual number of applications increased from 296 in 2010 to 1 971 in 2024, representing an average annual growth rate of 40.42%. Similarly, the number of funded projects grew from 45 in 2010 to 175 in 2024, with an average annual growth rate of 20.63%, while annual funding rose from 20.01 million RMB in 2010 to 74.20 million RMB in 2024, reflecting an average annual growth rate of 19.34%. The majority of funded projects belonged to the General Program (774 projects), Young Scientists Fund (754 projects), and Regional Science Fund (163 projects), collectively accounting for 94.95% of total funded projects (1 691/1 781). Funding was concentrated in two primary research areas: Organ Dysfunction and Support (H1602, 751 projects) and Sepsis (H1601, 612 projects), together comprising 76.53% of total funded projects (1 363/1 781). The total number of funded projects (1 781 projects) in Emergency and Critical Care Medicine was fewer than the average across the subfields of Medical Science Department (4 181 projects). Shanghai (305 projects, 17.1%), Guangdong (222 projects, 12.5%), Jiangsu (154 projects, 8.6%), Zhejiang (149 projects, 8.4%), and Beijing (134 projects, 7.5%) ranked as the top five regions in terms of funded projects. Keyword co-occurrence analysis revealed that sepsis, organ injury, pulmonary injury and poisoning, and cardiopulmonary resuscitation were the main research hotspots in the field of Emergency and Critical Care Medicine over the past 15 years.
CONCLUSION: From 2010 to 2024, the NSFC funding for the field of Emergency and Critical Care Medicine has shown a significant upward trajectory, providing vital support for the rapid advancement of basic and applied research. This growth has played a crucial role in facilitating the high-quality development of Emergency and Critical Care Medicine in China.
参考来源
- Zhou H, Du X, Fang D, et al. [Analysis of the application and funding status of National Natural Science Foundation of China in the field of Emergency and Critical Care Medicine from 2010 to 2024]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 39968580. doi:10.3760/cma.j.cn121430-20241204-00988
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。